U.S. markets closed
  • S&P 500

    +20.05 (+0.56%)
  • Dow 30

    +327.79 (+1.12%)
  • Nasdaq

    +25.66 (+0.22%)
  • Russell 2000

    +32.96 (+1.85%)
  • Crude Oil

    +0.44 (+1.04%)
  • Gold

    -37.50 (-2.00%)
  • Silver

    -0.74 (-3.03%)

    -0.0015 (-0.13%)
  • 10-Yr Bond

    +0.0280 (+3.38%)

    +0.0032 (+0.24%)

    +0.6220 (+0.60%)

    -57.94 (-0.31%)
  • CMC Crypto 200

    +3.86 (+1.07%)
  • FTSE 100

    -17.61 (-0.28%)
  • Nikkei 225

    -106.93 (-0.42%)

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of BIDU, PLAN and FENC

·3 min read

NEW YORK, NY / ACCESSWIRE / October 5, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Baidu, Inc. (NASDAQ:BIDU)
Class Period: April 8, 2016 - August 13, 2020
Lead Plaintiff Deadline: October 19, 2020

The complaint alleges that during the class period Baidu, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Baidu misrepresented the financial and business condition of iQIYI; (2) iQIYI had inadequate controls; and (3) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.

Learn about your recoverable losses in BIDU: http://www.kleinstocklaw.com/pslra-1/baidu-inc-loss-submission-form-2?id=9799&from=1

Anaplan Inc. (NYSE:PLAN)
Class Period: November 21, 2019 - February 26, 2020
Lead Plaintiff Deadline: October 23, 2020

The PLAN lawsuit alleges that throughout the class period, Anaplan Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was undergoing sales organization and execution challenges; (2) these organizational challenges were causing the Company to miss on closing very important large deals; and (3) as a result, Anaplan's financial guidance for "calculated billings growth" was baseless and unattainable. Further, while in possession of this material non-public information, Anaplan insiders dumped approximately $30 million worth of Anaplan stock at artificially inflated prices.

Learn about your recoverable losses in PLAN: http://www.kleinstocklaw.com/pslra-1/anaplan-inc-loss-submission-form?id=9799&from=1

Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
Class Period: February 11, 2020 - August 10, 2020
Lead Plaintiff Deadline: November 2, 2020

The FENC lawsuit alleges that Fennec Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the manufacturing facilities for PEDMARK, the Company's sole product candidate, did not comply with current good manufacturing practices; (2) as a result, regulatory approval for PEDMARK was reasonably likely to be delayed; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in FENC: http://www.kleinstocklaw.com/pslra-1/fennec-pharmaceuticals-inc-loss-submission-form?id=9799&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665

SOURCE: The Klein Law Firm

View source version on accesswire.com: